{"ticker": {"uuid": "bd8597c3-f9ca-48d1-a1cc-1d077670f908", "symbol": "300347", "name": "Hangzhou Tigermed Consulting Co., Ltd", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "ETFs Investing in Hangzhou Tigermed Consulting Co., Ltd. Class H Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE4zcXFDZ194bkJmdWpkY0hNN0R2T3NYVHo4WnZtc2p2aHN3V19UNWZrZ2Jpd1lpZVNNRGFnQTNVei1YOUw4MzZSdFJablpVU2V6WEdKdUdFb192bHRaam5r?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T21:16:41+00:00", "published_display": "12 Jul 2026 21:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Hangzhou Tigermed Consulting Co., Ltd. Class A \u2013 SZSE:300347", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQVzNzM2c0U2Z4MVQ5eDA3aFdKVTVfVWZ6U0VaUGVPeVhlTHNCMUxUZ0h3clduZ0FzY0IzOWZOSlB1RTBkWThKWE52SzZQdWEyaDFwNm1nMUxHRDRqZ3dFdk9NOXNYZEVSVlltekdxM0hIUDlUekcxZjhIUmdXSjJKSUpyaERpUXk2MFJlWkZGdDVTMkNvRV9ZSUszVWhBMzhYLWc?oc=5", "source_name": "TradingView", "published_at": "2026-07-06T21:16:21+00:00", "published_display": "06 Jul 2026 21:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hangzhou Tigermed Directors Investigated by CSRC for Suspected Information Disclosure Violations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOSXdlWS1CZVRka3BRS2E3ZHpBNzgyUXNRbHFIV1cxWWhTTUN0d3FBTmJNX1owQ2d1VUlUODZldGxsOWtmYi0xdmw5OWNHTkthQ1JPQVhnOVZfaUt5RVliVnpudzlJSloxenloMkl2Smp0ZkJYc1FiRVBXaWU0Z0NSaVRWNjVHREQ2dzhidnlrcm5qRFBGVVJieVBWMTRpTkN4RHRLX3Q4a2lPOEJ5UnQ1MXhBV25OTmlTZkU0WGtkU0Ita3JUU3I3OHdMbzRjSTZLUERn?oc=5", "source_name": "Minichart", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tigermed's Actual Controllers Ye Xiaoping, Cao Xiaochun Under CSRC Investigation; Hong Kong Shares Plunge Over 9% in Early Trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE1BOHZDTGM2U29PS3E2cU5TWWdlT0F6dUkxR1pmejktMmo0SHlxM2NxOXhsZTBzOGhSZ0NJdGE0cUcwMTBra3Z6NmlQMXAtalQ1bEtoQVpCZDBnTDBYaEJiaA?oc=5", "source_name": "finance.biggo.com", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tigermed roars in its Hong Kong trading debut with 19 per cent gain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2020-08-07T07:00:00+00:00", "published_display": "07 Aug 2020 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ETFs Investing in Hangzhou Tigermed Consulting Co., Ltd. Class H Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE4zcXFDZ194bkJmdWpkY0hNN0R2T3NYVHo4WnZtc2p2aHN3V19UNWZrZ2Jpd1lpZVNNRGFnQTNVei1YOUw4MzZSdFJablpVU2V6WEdKdUdFb192bHRaam5r?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T21:16:41+00:00", "published_display": "12 Jul 2026 21:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Hangzhou Tigermed Consulting Co., Ltd. Class A \u2013 SZSE:300347", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQVzNzM2c0U2Z4MVQ5eDA3aFdKVTVfVWZ6U0VaUGVPeVhlTHNCMUxUZ0h3clduZ0FzY0IzOWZOSlB1RTBkWThKWE52SzZQdWEyaDFwNm1nMUxHRDRqZ3dFdk9NOXNYZEVSVlltekdxM0hIUDlUekcxZjhIUmdXSjJKSUpyaERpUXk2MFJlWkZGdDVTMkNvRV9ZSUszVWhBMzhYLWc?oc=5", "source_name": "TradingView", "published_at": "2026-07-06T21:16:21+00:00", "published_display": "06 Jul 2026 21:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hangzhou Tigermed Directors Investigated by CSRC for Suspected Information Disclosure Violations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOSXdlWS1CZVRka3BRS2E3ZHpBNzgyUXNRbHFIV1cxWWhTTUN0d3FBTmJNX1owQ2d1VUlUODZldGxsOWtmYi0xdmw5OWNHTkthQ1JPQVhnOVZfaUt5RVliVnpudzlJSloxenloMkl2Smp0ZkJYc1FiRVBXaWU0Z0NSaVRWNjVHREQ2dzhidnlrcm5qRFBGVVJieVBWMTRpTkN4RHRLX3Q4a2lPOEJ5UnQ1MXhBV25OTmlTZkU0WGtkU0Ita3JUU3I3OHdMbzRjSTZLUERn?oc=5", "source_name": "Minichart", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tigermed's Actual Controllers Ye Xiaoping, Cao Xiaochun Under CSRC Investigation; Hong Kong Shares Plunge Over 9% in Early Trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE1BOHZDTGM2U29PS3E2cU5TWWdlT0F6dUkxR1pmejktMmo0SHlxM2NxOXhsZTBzOGhSZ0NJdGE0cUcwMTBra3Z6NmlQMXAtalQ1bEtoQVpCZDBnTDBYaEJiaA?oc=5", "source_name": "finance.biggo.com", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tigermed roars in its Hong Kong trading debut with 19 per cent gain", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2020-08-07T07:00:00+00:00", "published_display": "07 Aug 2020 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 59, "total_relevant": 5, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 3, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 68, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 49.02, "latest_week": "2026-07-17", "one_week_move": 3.7, "four_week_move": 22.5, "twelve_week_move": -12.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.096037, "market_dynamics_buy_signal": true, "relative_strength": -12.58917, "fair_value_gap": -11.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.1853, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.7% over one week, +22.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 54, "badges": ["Market Dynamics buy signal"], "opportunities": ["Market Dynamics is showing a buy signal in the latest weekly context."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "Minichart", "count": 1}, {"label": "finance.biggo.com", "count": 1}, {"label": "South China Morning Post", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Earnings", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "68/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.7% over one week, +22.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ETFs Investing in Hangzhou Tigermed Consulting Co., Ltd. Class H Stocks"}], "updated_at": "2026-07-21T22:38:08.507391+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}